• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (5074212)   Today's Articles (191)
For: Borrebaeck CA, Carlsson R. Human therapeutic antibodies. Curr Opin Pharmacol 2001;1:404-8. [PMID: 11710740 DOI: 10.1016/s1471-4892(01)00070-4] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Number Cited by Other Article(s)
1
Jafarzadeh A, Saffari F. Development of anti-rituximab antibodies in rituximab-treated patients: Related parameters & consequences. Indian J Med Res 2022;155:335-346. [DOI: 10.4103/ijmr.ijmr_312_19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]  Open
2
Makowski EK, Wu L, Gupta P, Tessier PM. Discovery-stage identification of drug-like antibodies using emerging experimental and computational methods. MAbs 2021;13:1895540. [PMID: 34313532 PMCID: PMC8346245 DOI: 10.1080/19420862.2021.1895540] [Citation(s) in RCA: 37] [Impact Index Per Article: 9.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2020] [Revised: 02/05/2021] [Accepted: 02/22/2021] [Indexed: 11/30/2022]  Open
3
Peptides, Antibodies, Peptide Antibodies and More. Int J Mol Sci 2019;20:ijms20246289. [PMID: 31847088 PMCID: PMC6941022 DOI: 10.3390/ijms20246289] [Citation(s) in RCA: 84] [Impact Index Per Article: 14.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2019] [Revised: 12/02/2019] [Accepted: 12/05/2019] [Indexed: 02/07/2023]  Open
4
Kim HS, Lee JH, Roh KH, Jun HJ, Kang KS, Kim TY. Clinical Trial of Human Umbilical Cord Blood-Derived Stem Cells for the Treatment of Moderate-to-Severe Atopic Dermatitis: Phase I/IIa Studies. Stem Cells 2016;35:248-255. [DOI: 10.1002/stem.2401] [Citation(s) in RCA: 88] [Impact Index Per Article: 9.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2016] [Revised: 04/24/2016] [Accepted: 05/09/2016] [Indexed: 12/13/2022]
5
Qi J, Ye X, Ren G, Kan F, Zhang Y, Guo M, Zhang Z, Li D. Pharmacological efficacy of anti-IL-1β scFv, Fab and full-length antibodies in treatment of rheumatoid arthritis. Mol Immunol 2014;57:59-65. [DOI: 10.1016/j.molimm.2013.08.002] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/09/2013] [Revised: 08/02/2013] [Accepted: 08/04/2013] [Indexed: 10/26/2022]
6
Glassy MC, Gupta R. Technical and ethical limitations in making human monoclonal antibodies (an overview). Methods Mol Biol 2014;1060:9-36. [PMID: 24037834 DOI: 10.1007/978-1-62703-586-6_2] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/02/2023]
7
Ansar W, Ghosh S. Monoclonal Antibodies: A Tool in Clinical Research. ACTA ACUST UNITED AC 2013. [DOI: 10.4137/ijcm.s11968] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
8
Gorlani A, Hulsik DL, Adams H, Vriend G, Hermans P, Verrips T. Antibody engineering reveals the important role of J segments in the production efficiency of llama single-domain antibodies in Saccharomyces cerevisiae. Protein Eng Des Sel 2011;25:39-46. [PMID: 22143875 DOI: 10.1093/protein/gzr057] [Citation(s) in RCA: 29] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]  Open
9
Chames P, Van Regenmortel M, Weiss E, Baty D. Therapeutic antibodies: successes, limitations and hopes for the future. Br J Pharmacol 2009;157:220-33. [PMID: 19459844 PMCID: PMC2697811 DOI: 10.1111/j.1476-5381.2009.00190.x] [Citation(s) in RCA: 1207] [Impact Index Per Article: 75.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2008] [Revised: 09/01/2008] [Accepted: 01/12/2009] [Indexed: 11/28/2022]  Open
10
Ellmark P, Andersson H, Abayneh S, Fenyö EM, Borrebaeck CA. Identification of a strongly activating human anti-CD40 antibody that suppresses HIV type 1 infection. AIDS Res Hum Retroviruses 2008;24:367-73. [PMID: 18327984 DOI: 10.1089/aid.2007.0215] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]  Open
11
Construction of miniantibodies for the in vivo study of human autoimmune diseases in animal models. BMC Biotechnol 2007;7:46. [PMID: 17678525 PMCID: PMC1963447 DOI: 10.1186/1472-6750-7-46] [Citation(s) in RCA: 39] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2007] [Accepted: 08/01/2007] [Indexed: 12/04/2022]  Open
12
Srebalus Barnes CA, Lim A. Applications of mass spectrometry for the structural characterization of recombinant protein pharmaceuticals. MASS SPECTROMETRY REVIEWS 2007;26:370-88. [PMID: 17410555 DOI: 10.1002/mas.20129] [Citation(s) in RCA: 128] [Impact Index Per Article: 7.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/14/2023]
13
Kubetzko S, Balic E, Waibel R, Zangemeister-Wittke U, Plückthun A. PEGylation and multimerization of the anti-p185HER-2 single chain Fv fragment 4D5: effects on tumor targeting. J Biol Chem 2006;281:35186-201. [PMID: 16963450 DOI: 10.1074/jbc.m604127200] [Citation(s) in RCA: 87] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]  Open
14
Teerinen T, Valjakka J, Rouvinen J, Takkinen K. Structure-based Stability Engineering of the Mouse IgG1 Fab Fragment by Modifying Constant Domains. J Mol Biol 2006;361:687-97. [PMID: 16876195 DOI: 10.1016/j.jmb.2006.06.073] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2006] [Revised: 06/19/2006] [Accepted: 06/21/2006] [Indexed: 11/17/2022]
15
Ek S, Andréasson U, Hober S, Kampf C, Pontén F, Uhlén M, Merz H, Borrebaeck CAK. From Gene Expression Analysis to Tissue Microarrays. Mol Cell Proteomics 2006;5:1072-81. [PMID: 16524965 DOI: 10.1074/mcp.m600077-mcp200] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]  Open
16
Röthlisberger D, Honegger A, Plückthun A. Domain Interactions in the Fab Fragment: A Comparative Evaluation of the Single-chain Fv and Fab Format Engineered with Variable Domains of Different Stability. J Mol Biol 2005;347:773-89. [PMID: 15769469 DOI: 10.1016/j.jmb.2005.01.053] [Citation(s) in RCA: 227] [Impact Index Per Article: 11.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/20/2004] [Revised: 01/09/2005] [Accepted: 01/20/2005] [Indexed: 11/25/2022]
17
Wang X, Zhao H, Andersson R. Proteomics and leukocytes: an approach to understanding potential molecular mechanisms of inflammatory responses. J Proteome Res 2004;3:921-929. [PMID: 15473680 DOI: 10.1021/pr0499601] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
18
Fransson J, Ek S, Ellmark P, Söderlind E, Borrebaeck CAK, Furebring C. Profiling of internalizing tumor-associated antigens on breast and pancreatic cancer cells by reversed genomics. Cancer Lett 2004;208:235-42. [PMID: 15142683 DOI: 10.1016/j.canlet.2003.11.036] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/03/2003] [Revised: 11/26/2003] [Accepted: 11/28/2003] [Indexed: 11/23/2022]
19
Malmborg Hager AC, Ellmark P, Borrebaeck CAK, Furebring C. Affinity and epitope profiling of mouse anti-CD40 monoclonal antibodies. Scand J Immunol 2003;57:517-24. [PMID: 12791089 DOI: 10.1046/j.1365-3083.2003.01271.x] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
20
Souriau C, Hudson PJ. Recombinant antibodies for cancer diagnosis and therapy. Expert Opin Biol Ther 2003;3:305-18. [PMID: 12662144 DOI: 10.1517/14712598.3.2.305] [Citation(s) in RCA: 54] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA